Patient Transfer Program for Transitioning From Exubera (Insulin Human [rDNA Origin]) Inhalation Powder to Technosphere Insulin (Insulin Human [rDNA Origin]) Inhalation Powder

Trial Profile

Patient Transfer Program for Transitioning From Exubera (Insulin Human [rDNA Origin]) Inhalation Powder to Technosphere Insulin (Insulin Human [rDNA Origin]) Inhalation Powder

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Jun 2017

At a glance

  • Drugs Insulin (Primary)
  • Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Adverse reactions; Expanded access
  • Sponsors MannKind Corporation
  • Most Recent Events

    • 14 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Dec 2014 Planned End Date changed from 1 Jun 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov.
    • 13 Dec 2013 Planned End Date changed from 1 Jan 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top